TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles

Molecular Oncology

Volumn 2, Issue 3, 2008, Pages 233-240

  Offenberg, Hanne ^a   Brünner, Nils ^a   Mansilla, Francisco ^b   Orntoft Torben F ^b   Birkenkamp Demtroder, Karin ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Colorectal cancer; Gene expression profiling; TIMP 1

Indexed keywords

ACTIVIN A; ENZYME; LYSYL OXIDASE 2; PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 6; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LYSYL OXIDASE 2 GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 6 GENE; UPREGULATION;

AMINO ACID OXIDOREDUCTASES; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBIN-BETA SUBUNITS; MATRIX METALLOPROTEINASES; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 51249101302     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2008.06.003     Document Type: Article

References (32)

1. Akahane T., Akahane M., Shah A., Connor C.M., and Thorgeirsson U.P. TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms. Experimental Cell Research 301 (2004) 158-167
2. Baker E.A., Bergin F.G., and Leaper D.J. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. British Journal of Surgery 87 (2000) 1215-1221
3. Birkenkamp-Demtroder K., Christensen L.L., Olesen S.H., Frederiksen C.M., Laiho P., Aaltonen L.A., Laurberg S., Sorensen F.B., Hagemann R., and Orntoft T.F. Gene expression in colorectal cancer. Cancer Research 62 (2002) 4352-4363
4. Birkenkamp-Demtroder K., Olesen S.H., Sorensen F.B., Laurberg S., Laiho P., Aaltonen L.A., and Orntoft T.F. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54 (2005) 374-384
5. Birkenkamp-Demtroder K., Mansilla F., Sørensen F.B., Kruhøffer M., Christensen L., Aaltonen L.A., Verspaget H., and Ørntoft T.F. Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancers in vivo and impacts viability and proliferation in vitro. Molecular Oncology 1 (2007) 181-195
6. Bister V.O., Salmela M.T., Karjalainen-Lindsberg M.L., Uria J., Lohi J., Puolakkainen P., Lopez-Otin C., and Saarialho-Kere U. Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer. Digestive Diseases and Sciences 49 (2004) 653-661
7. Daniel P., Wagrowska-Danilewicz M., Danilewicz M., Stasikowska O., and Malecka-Panas E. Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma. International Journal of Colorectal Disease 22 (2007) 1165-1172
8. Davidsen M.L., Wurtz S.O., Romer M.U., Sorensen N.M., Johansen S.K., Christensen I.J., Larsen J.K., Offenberg H., Brunner N., and Lademann U. TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis. British Journal of Cancer 95 (2006) 1114-1120
9. Ellenrieder V., Hendler S.F., Ruhland C., Boeck W., Adler G., and Gress T.M. TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. International Journal of Cancer 93 (2001) 204-211
10. Fong S.F., Dietzsch E., Fong K.S., Hollosi P., Asuncion L., He Q., Parker M.I., and Csiszar K. Lysyl oxidase-like 2 expression is increased in colon and esophageal tumours and associated with less differentiated colon tumours. Genes Chromosomes Cancer 46 (2007) 644-655
11. Guedez L., Courtemanch L., and Stetler-Stevenson M. Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B Cells. Blood 92 (1998) 1342-1349
12. Guillem J.G., Levy M.F., Hsieh L.L., Johnson M.D., LoGerfo P., Forde K.A., and Weinstein I.B. Increased levels of phorbin, c-myc, and ornithine decarboxylase RNAs in human colon cancer. Molecular Carcinogenesis 3 (1990) 68-74
13. Holten-Andersen M.N., Stephens R.W., Nielsen H.J., Murphy G., Christensen I.J., Stetler-Stevenson W., and Brunner N. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. Clinical Cancer Research 6 (2000) 4292-4299
14. Holten-Andersen M.N., Christensen I.J., Nielsen H.J., Stephens R.W., Jensen V., Nielsen O.H., Sorensen S., Overgaard J., Lilja H., Harris A., Murphy G., and Brunner N. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. Clinical Cancer Research 8 (2002) 156-164
15. Holten-Andersen M.N., Hansen U., Brunner N., Nielsen H.J., Illemann M., and Nielsen B.S. Localization of tissue inhibitor of metalloproteinases 1 (TIMP-1) in human colorectal adenoma and adenocarcinoma. International Journal of Cancer 113 (2005) 198-206
16. Jung K.K., Liu X.W., Chirco R., Fridman R., and Kim H.R.C. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO Journal 25 (2006) 3934-3942
17. Kruhoffer M., Jensen J.L., Laiho P., Dyrskjot L., Salovaara R., Arango D., Birkenkamp-Demtroder K., Sorensen F.B., Christensen L.L., Buhl L., Mecklin J.P., Jarvinen H., Thykjaer T., Wikman F.P., Bech-Knudsen F., Juhola M., Nupponen N.N., Laurberg S., Andersen C.L., Aaltonen L.A., and Orntoft T.F. Gene expression signatures for colorectal cancer microsatellite status and HNPCC. British Journal of Cancer 92 (2005) 2240-2248
18. Liu X.W., Bernardo M.M., Fridman R., and Kim H.R.C. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. Journal of Biological Chemistry 278 (2003) 40364-40372
19. Liu X.W., Taube M.E., Jung K.K., Dong Z., Lee Y.J., Roshy S., Sloane B.F., Fridman R., and Kim H.R.C. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: A potential oncogenic activity of tissue inhibitor of metalloproteinase-1. Cancer Research 65 (2005) 898-906
20. Mansilla F., Birkenkamp-Demtroder K., Kruhoffer M., Sorensen F.B., Andersen C.L., Laiho P., Aaltonen L.A., Verspaget H.W., and Orntoft T.F. Differential expression of DHHC9 in microsatellite stable and instable human colorectal cancer subgroups. British Journal of Cancer 96 (2007) 1896-1903 10.1038/sj.bjc.6603818
21. Matsushita M., Matsuzaki K., Date M., Watanabe T., Shibano K., Nakagawa T., Yanagitani S., Amoh Y., Takemoto H., Ogata N., Yamamoto C., Kubota Y., Seki F., Inokuchi H., Nishizawa M., Takada H., Sawamura T., Okamura A., and Inoue K. Down regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development. British Journal of Cancer 80 (1999) 194-205
22. Nagase H., and Woessner J.F. Matrix metalloproteinases. Journal of Biological Chemistry 274 (1999) 21491-21494
23. Peinado H., del Carmen M., de la Cruz I., Olmeda D., Csiszar K., Fong K.S.K., Vega S., Nieto M.A., Cano A., and Portillo F. A molecular role for lysyl oxidase-like 2 enzyme in Snail regulation and tumour progression. EMBO Journal 24 (2005) 3446-3458
24. Powe D.G., Brough J.L., Carter G.I., Bailey E.M., StetlerStevenson W.G., Turner D.R., and Hewitt R.E. TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma. British Journal of Cancer 75 (1997) 1678-1683
25. Schrohl A.S., Holten-Andersen M.N., Peters H.A., Look M.P., Meijer-van Gelder M.E., Klijn J.G., Brunner N., and Foekens J.A. Tumour tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer. Clinical Cancer Research 10 (2004) 2289-2298
26. Schrohl A.S., Meijer-van Gelder M.E., Holten-Andersen M.N., Christensen I.J., Look M.P., Mouridsen H.T., Brunner N., and Foekens J.A. Primary tumour levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer. Clinical Cancer Research 12 (2006) 7054-7058
27. Sieuwerts A.M., Klijn J.G.M., Henzen-Logmans S.C., Bouwman I., Van Roozendaal K.E.P., Peters H.A., Setyono-Han B., and Foekens J.A. Urokinase-type-plasminogen-activator (uPA) production by human breast (myo)fibroblasts in vitro: Influence of transforming growth factor-beta(1) (TGF beta(1)) compared with factor(s) released by human epithelial-carcinoma cells. International Journal of Cancer 76 (1998) 829-835
28. Sorensen N.M., Bystrom P., Christensen I.J., Berglund A., Nielsen H.J., Brunner N., and Glimelius B. TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid. Clinical Cancer Research 13 (2007) 4117-4122
29. Tanaka Y., Kobayashi H., Suzuki M., Kanayama N., and Terao T. Transforming growth factor-beta 1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. Journal of Biological Chemistry 279 (2004) 8567-8576
30. Westbrook C.A., Gasson J.C., Gerber S.E., Selsted M.E., and Golde D.W. Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity. Journal of Biological Chemistry 259 (1984) 9992-9996
31. Wildi S., Kleeff J., Maruyama H., Maurer C.A., Buchler M.W., and Korc M. Overexpression of activin A in stage IV colorectal cancer. Gut 49 (2001) 409-417
32. Zucker S., and Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer and Metastasis Reviews 23 (2004) 101-117